Valuation: Nexstim Oyj

Market Cap 75.98M 87.73M 70.83M 65.15M 123M 8.34B 124M 832M 327M 4.17B 330M 322M 13.82B P/E 2026 *
78.4x
P/E 2027 * 34.9x
Enterprise Value 73.88M 85.31M 68.87M 63.35M 120M 8.11B 121M 809M 318M 4.06B 320M 313M 13.44B EV / Sales 2026 *
5.82x
EV / Sales 2027 * 4.49x
Free-Float
58.2%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 50 11/02/2020
Director of Finance/CFO 40 11/02/2020
Chief Tech/Sci/R&D Officer 65 01/01/2008
Director TitleAgeSince
Director/Board Member 64 11/11/2019
Chairman 63 11/11/2019
Director/Board Member 55 01/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
-6.90%-5.73% - - 87.51M
+2.05%-0.04%+23.55%+4.43% 209B
+1.75%+0.92%-0.37%-22.42% 137B
+1.68%+6.13%-21.43%+21.19% 130B
-3.89%+2.56%-54.96%-6.92% 71.14B
-1.04%+3.43%+11.94%+11.10% 51.59B
+0.62%+4.53%-14.27%-19.57% 49.99B
+1.21%+0.32%+22.51%+11.26% 39.31B
+1.01%+5.43%+42.29%+38.10% 38.89B
+0.00%+3.82%-21.94%+19.18% 32.19B
Average -0.39%+3.19%-1.41%+6.26% 84.33B
Weighted average by Cap. +0.87%+1.42%-0.14%+2.97%

Financials

2026 *2027 *
Net sales 12.7M 14.66M 11.84M 10.89M 20.56M 1.39B 20.79M 139M 54.6M 698M 55.07M 53.86M 2.31B 16.1M 18.59M 15.01M 13.8M 26.06M 1.77B 26.35M 176M 69.22M 884M 69.82M 68.28M 2.93B
Net income 1M 1.15M 932K 857K 1.62M 110M 1.64M 10.95M 4.3M 54.93M 4.34M 4.24M 182M 2.2M 2.54M 2.05M 1.89M 3.56M 242M 3.6M 24.1M 9.46M 121M 9.54M 9.33M 400M
Net Debt -2.1M -2.42M -1.96M -1.8M -3.4M -231M -3.44M -23M -9.03M -115M -9.11M -8.91M -382M -3.7M -4.27M -3.45M -3.17M -5.99M -406M -6.06M -40.53M -15.91M -203M -16.04M -15.69M -673M
Logo Nexstim Oyj
Nexstim Oyj is a Finland-based medical technology company. It is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Company’s systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-